loading

Pulse Biosciences Inc Azioni (PLSE) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Research and Development
17.21%
12.09
10.31 10.66 7.703 7.23
Costs And Expenses
12.36%
20.27
18.04 20.26 13.65 11.73
Operating Income/Loss
12.36%
-20.27
-18.04 -20.26 -13.65 -11.73
Nonoperating Income/Loss
11.37%
1.107
1.249 0.876 0.975 0.343
Income/Loss From Continuing Operations Before Tax
14.13%
-19.17
-16.80 -19.39 -12.68 -11.38
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
14.13%
-19.17
-16.80 -19.39 -12.68 -11.38
Net Income/Loss
14.13%
-19.17
-16.80 -19.39 -12.68 -11.38
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.22%
67.28
67.13 1.229 61.07 57.18
Basic Earnings Per Share
12.00%
-0.28
-0.25 -0.32 -0.21 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$14.57
price up icon 5.05%
medical_instruments_supplies BAX
$22.97
price up icon 0.97%
$71.44
price down icon 0.17%
medical_instruments_supplies COO
$71.56
price up icon 4.07%
$68.50
price up icon 2.24%
medical_instruments_supplies WST
$267.19
price up icon 1.61%
Capitalizzazione:     |  Volume (24 ore):